Heated humidified high-flow therapy

Heated humidified high-flow therapy, often known as high flow nasal cannula (HFNC) or high flow therapy (HFT), is a type of respiratory support that delivers a flow of medical gas to a patient of up to 60 L/min and 100% oxygen through a large bore nasal cannula. Primarily studied in neonates, it has also been found effective in some adults to treat hypoxemia and work of breathing issues. The key components of it are a gas blender, heated humidifier, heated circuit, and cannula.[1]

High-flow therapy
Illustration of a patient using HFT device
Other namesHigh flow nasal cannula
ICD-10-PCSZ99.81

History

Traditional Nasal cannulas used for medical gas delivery are limited to delivery of 1–6 liters of per minute of oxygen or up to 15 L/min in certain types. Even with quiet breathing, the inspiratory flow rate at the nares of an adult usually exceeds 30 L/min. Therefore, the oxygen is diluted with room air during inspiration.[2]

High flow nasal cannula was introduced in the early 2000s to treat apnea in premature neonates where it has been shown to be very affective.[3]

The percent oxygen inhaled by the patient (FiO2), usually ranges roughly 24–44% as the pure oxygen delivered from the cannula is diluted by entrainment of ambient air. Flow rates for delivery of oxygen using typical nasal cannula are limited because medical oxygen is anhydrous, and when delivered from a pressurized source the gas cools as it expands with the drop to atmospheric pressure. Delivery of cold dry gas is irritating to the respiratory mucosa, can cause drying and bleeding of the nasal mucosa and can increase metabolic demand by cooling the body.[4]

Prior to the advent of HFT, when increased FiO2 was required for respiratory support; special face masks or intubation was required. With High Flow Therapy, the goal is to deliver a respiratory gas flow volume sufficient to meet or exceed the patient's inspiratory flow rate. The gas is heated and humidified to condition the gas as increased flows would be detrimental to tissue if left dry and cool.

HFT is a source of oxygen is usually blended with compressed air. Hospitals usually have 50 psi (350 kPa) compressed oxygen and air available for therapeutic use. This allows the delivery of air or blends of air and oxygen with the use of an oxygen blender. The gas is then heated, generally to about 31-37 °C, and humidified to near 100% RH using a humidifier. The gas is transported to the patient through a heated delivery tube to prevent cooling and condensation of the water vapor in the tubing..

HFT requires the use of nasal cannulas and a system designed to deliver high flow rates and the pressure generated to do so. At the same time the nasal cannula must be small enough that they do not occlude more than 50% of the nares, as this allows flow to have multiple points of exit for a continuous airway flush effect.

Commercial developments

Vapotherm introduced the concept of heated humidified high flow therapy via nasal cannula in 1999 after being originally developed for use in race horses.[5]

Medical uses

High-flow therapy is useful in patients that are spontaneously breathing but have an increased work of breathing. Conditions such as general respiratory failure, asthma exacerbation, COPD exacerbation, bronchiolitis, pneumonia, and congestive heart failure are all possible situations where high-flow therapy may be indicated.[6] Heated humidified high-flow therapy has been used in spontaneously breathing patients with during general anesthesia to facilitate surgery for airway obstruction.[7]

Newborn babies

High-flow therapy has shown to be useful in neonatal intensive care settings for premature infants with Infant respiratory distress syndrome,[8] as it prevents many infants from needing artificial ventilation via intubation, and allows safe respiratory management at lower FiO2 levels, and thus reduces the risk of retinopathy of prematurity and oxygen toxicity.

Due to the decreased stress of effort needed to breathe, the neonatal body is able to spend more time utilizing metabolic efforts elsewhere, which causes decreased days on a mechanical ventilator, faster weight gain, and overall decreased hospital stay entirely.[9]

High flow therapy has been successfully implemented in infants and older children. The cannula improves the respiratory distress, the oxygen saturation, and the patient's comfort. Its mechanism of action is the application of mild positive airway pressure and lung volume recruitment.[10]

Benefits

HFT, the clinician can deliver higher FiO2 to the patient than is possible with typical oxygen delivery therapy without the use of a non-rebreather mask or tracheal intubation. Heated humidification of the respiratory gas facilitates secretion clearance and decreases the development of bronchial hyper-response symptoms.[11] Some patients requiring respiratory support for bronchospasm benefit using air delivered by HFT without additional oxygen.[12] HFT is useful in the treatment of sleep apnea.[13] During use of HFT the patient can speak. As this is a non-invasive therapy, it avoids the risk of ventilator-associated pneumonia in situations where it can supplant the use of a ventilator.

Use of nasal high flow in acute hypoxemic respiratory failure does not affect mortality or length of stay either in hospital or in the intensive care unit. It does however reduce the need for tracheal intubation (by 15%) and escalation of oxygenation and respiratory support. However, the certainty that this result is reliable is low, as different studies were less precise than they could have been. People on nasal high flow feel more comfortable, less breathless, and there was little evidence of harm.[14][15]

Mechanism

Oxygenation is achieved by providing an increased FiO2 in the flow to the patient. The washout of the upper airway creates a reservoir that reduces room-air entrainment to such an amount that it becomes a true fraction of inspired oxygen as set by the device.

Ventilation

Through a cannula in the nose, a high-flow system delivers flows that approach (and can meet) total respiratory demand.[16] This flow, being delivered though a small diameter delivery system and small-bore nasal cannula allows the flow that would traditionally move slowly through the upper airway to move quickly and maintain a constant stream of fresh gas which effectively washes out upper airway dead space.[17]

This constant stream of fresh gas flow creates an environment that assists exhalation effort by flushing the exhaled air out to maintain this reservoir of fresh air ready to be inhaled.

Humidification

The higher the flow, the more important proper humidification and conditioning of the flow becomes. Without humidity, the oxygenation and ventilation effects of high-flow therapy would be overcome by the negative impact that dry air has on lung tissue.[18][19][20]

References
  1. Nishimura M (April 2016). "High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects". Respiratory Care. 61 (4): 529–541. doi:10.4187/respcare.04577. PMID 27016353. S2CID 11360190.
  2. Puddy A, Younes M (September 1992). "Effect of inspiratory flow rate on respiratory output in normal subjects". The American Review of Respiratory Disease. 146 (3): 787–789. doi:10.1164/ajrccm/146.3.787. PMID 1519864.
  3. Spicuzza L, Schisano M (2020). "High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future". Therapeutic Advances in Chronic Disease. 11: 2040622320920106. doi:10.1177/2040622320920106. PMC 7238775. PMID 32489572.
  4. Waugh JB, Granger WM (August 2004). "An evaluation of 2 new devices for nasal high-flow gas therapy". Respiratory Care. 49 (8): 902–906. PMID 15271229.
  5. Waugh J. "High Flow Oxygen Delivery" (PDF). Trends in Noninvasive Respiratory Support: Continuum of Care. Clinical Foundations. Archived from the original (PDF) on 24 April 2014. Retrieved 24 April 2014.
    • US patent (expired) 4722334, Blackmer RH, Hedman JW, "Method and apparatus for pulmonary and cardiovascular conditioning of racehorses and competition animals", issued 1988-02-02
  6. Veenstra P, Veeger NJ, Koppers RJ, Duiverman ML, van Geffen WH (2022-10-05). "High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study". PLOS ONE. 17 (10): e0272372. Bibcode:2022PLoSO..1772372V. doi:10.1371/journal.pone.0272372. PMC 9534431. PMID 36197917.
  7. Booth AW, Vidhani K, Lee PK, Thomsett CM (March 2017). "SponTaneous Respiration using IntraVEnous anaesthesia and Hi-flow nasal oxygen (STRIVE Hi) maintains oxygenation and airway patency during management of the obstructed airway: an observational study". British Journal of Anaesthesia. 118 (3): 444–451. doi:10.1093/bja/aew468. PMC 5409133. PMID 28203745.
  8. Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ (February 2007). "High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study". Journal of Perinatology. 27 (2): 85–91. doi:10.1038/sj.jp.7211647. PMID 17262040. S2CID 25835575.
  9. Holleman-Duray D, Kaupie D, Weiss MG (December 2007). "Heated humidified high-flow nasal cannula: use and a neonatal early extubation protocol". Journal of Perinatology. 27 (12): 776–781. doi:10.1038/sj.jp.7211825. PMID 17855805.
  10. Spentzas T, Minarik M, Patters AB, Vinson B, Stidham G (2009-10-01). "Children with respiratory distress treated with high-flow nasal cannula". Journal of Intensive Care Medicine. 24 (5): 323–328. doi:10.1177/0885066609340622. PMID 19703816. S2CID 25585432.
  11. Roca O, Riera J, Torres F, Masclans JR (April 2010). "High-flow oxygen therapy in acute respiratory failure". Respiratory Care. 55 (4): 408–413. PMID 20406507.
  12. Waugh JB, Granger WM (August 2004). "An evaluation of 2 new devices for nasal high-flow gas therapy". Respiratory Care. 49 (8): 902–906. PMID 15271229.
  13. McGinley BM, Patil SP, Kirkness JP, Smith PL, Schwartz AR, Schneider H (July 2007). "A nasal cannula can be used to treat obstructive sleep apnea". American Journal of Respiratory and Critical Care Medicine. 176 (2): 194–200. doi:10.1164/rccm.200609-1336OC. PMC 1994212. PMID 17363769.
  14. Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S, Frat JP, et al. (May 2019). "High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis". Intensive Care Medicine. 45 (5): 563–572. doi:10.1007/s00134-019-05590-5. PMID 30888444. S2CID 83463457.
  15. Veenstra P, Veeger NJ, Koppers RJ, Duiverman ML, van Geffen WH (2022-10-05). "High-flow nasal cannula oxygen therapy for admitted COPD-patients. A retrospective cohort study". PLOS ONE. 17 (10): e0272372. Bibcode:2022PLoSO..1772372V. doi:10.1371/journal.pone.0272372. PMC 9534431. PMID 36197917.
  16. Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, et al. (January 2011). "High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model". Pediatric Pulmonology. 46 (1): 67–74. doi:10.1002/ppul.21326. PMC 3332105. PMID 21171186..
  17. Dysart K, Miller TL, Wolfson MR, Shaffer TH (October 2009). "Research in high flow therapy: mechanisms of action". Respiratory Medicine. 103 (10): 1400–1405. doi:10.1016/j.rmed.2009.04.007. PMID 19467849. (Review).
  18. Rea H, McAuley S, Jayaram L, Garrett J, Hockey H, Storey L, et al. (April 2010). "The clinical utility of long-term humidification therapy in chronic airway disease". Respiratory Medicine. 104 (4): 525–533. doi:10.1016/j.rmed.2009.12.016. PMID 20144858.
  19. Solomita M, Daroowalla F, Leblanc DS, Smaldone GC (April 2009). "Y-piece temperature and humidification during mechanical ventilation". Respiratory Care. 54 (4): 480–486. PMID 19327183.
  20. Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE (2008). "Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis". Chronic Respiratory Disease. 5 (2): 81–86. doi:10.1177/1479972307087190. PMID 18539721. S2CID 206736621.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.